DENA NOVAK: Open Payments
NPI 1629345087 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,078 in 60 payments from 11 companies in 2025. Trend: 2023 $457 · 2024 $1,191 · 2025 $1,078
Food & beverage: $1,078
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $409 |
| Neurocrine BioSciences, Inc. | 5 | $115 |
| Neurelis, Inc. | 4 | $111 |
| JAZZ PHARMACEUTICALS INC. | 5 | $90 |
| UCB, Inc. | 4 | $74 |
| SK Life Science, Inc. | 3 | $70 |
| ACADIA Pharmaceuticals Inc | 3 | $60 |
| ANI Pharmaceuticals, Inc. | 3 | $53 |
| LivaNova USA, Inc. | 2 | $48 |
| PFIZER INC. | 2 | $30 |
Products named: UBRELVY, BOTOX, INGREZZA, VALTOCO, QULIPTA, EPIDIOLEX, PURIFIED CORTROPHIN GEL, VNS THERAPY SENTIVA MODEL 1000 GENERATOR.
Industry payments across LA — which companies pay providers there.
